End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.96 BGN | 0.00% | -2.30% | +4.20% |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sales 2024 * | 1.99B 1.09B | Sales 2025 * | - | Capitalization | 987M 541M |
---|---|---|---|---|---|
Net income 2024 * | 72M 39.46M | Net income 2025 * | - | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
5.03% | Yield 2025 * |
-
| Free-Float | 30.85% |
1 week | -2.30% | ||
Current month | -3.87% | ||
1 month | -5.99% | ||
3 months | -1.00% | ||
6 months | -13.37% | ||
Current year | +4.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 5.96 | 0.00% | 1,068 |
24-04-24 | 5.96 | +1.71% | 17 |
24-04-23 | 5.86 | -3.30% | 15,747 |
24-04-22 | 6.06 | +0.33% | 1,805 |
24-04-19 | 6.04 | -0.98% | 7,964 |
End-of-day quote Bulgaria S.E., April 24, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.20% | 541M | |
-32.59% | 15.18B | |
-31.97% | 10.1B | |
+9.54% | 6.12B | |
-11.41% | 5.97B | |
-30.42% | 5.65B | |
-0.88% | 4.71B | |
+51.58% | 4.26B | |
-12.22% | 3.58B | |
-16.75% | 3.26B |
- Stock Market
- Equities
- SFA Stock